GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Extreme stock market volatility will inevitably prompt some income investors to declare that “cash is king”. After all, cash ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Biotech has been hard hit, as one might expect, leaving many names in bargain territory. Learn why there are opportunities amidst market volatility.

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

When pressed for 2025 expectations, Verona believed $254 million in revenues was a fair estimate. Critically, Verona expects ...

In the wake of heightened global trade tensions and significant market volatility, investors are increasingly cautious as they navigate an environment marked by steep declines in major indices. Amidst ...

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

GSK market cap is currently £59.69B and has a P/E ratio of 23.26. Based on the recent corporate insider activity of 311 insiders, corporate insider sentiment is negative on the stock. This means ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...